Status:
COMPLETED
Cilostazol and Its Effects on Resumption of Meiosis in the Human Ovary
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
Society of Family Planning
Conditions:
Contraception
Eligibility:
FEMALE
18-33 years
Phase:
PHASE2
Brief Summary
Combined oral contraceptive pills (COCs) are the most commonly used hormonal form of birth control in the United States with at least 87% of women of reproductive age reporting oral contraceptive use ...
Detailed Description
Combined oral contraceptive pills (COCs) are the most commonly used hormonal form of birth control in the United States with at least 87% of women of reproductive age reporting oral contraceptive use ...
Eligibility Criteria
Inclusion
- previous oocyte donor in USC IVF clinic within past 3 years
- age 18-33
- willingness and ability to commit to the time requirements of the study
- willingness to donate oocytes for research purposes
- willingness to discontinue current hormonal contraception
- otherwise healthy subjects
Exclusion
- contraindications to combined hormonal contraceptive use (CDC MEC class 3 or 4)
- pregnancy
- history of cardiac arrhythmias
- history of heart failure
- history of bleeding disorder
- concomitant use of anti-platelet therapy such as aspirin
- current use of drugs that inhibit cytochrome P450 CYP 3A4 (erythromycin, diltiazem, ketoconazole, itraconazole) or CYP 2C19 (omeprazole) as they may lead to increased serum levels of cilostazol.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01915069
Start Date
July 1 2013
End Date
August 1 2014
Last Update
May 12 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California Fertility Clinic
Los Angeles, California, United States, 90017